Boardroom Turmoil at Novo Nordisk Signals Strategic Shifts Amid Market Pressures
Leadership Shakeup Reflects Deeper Strategic Divisions Novo Nordisk, the Danish pharmaceutical giant behind blockbuster drugs Ozempic and Wegovy, is experiencing…
Leadership Shakeup Reflects Deeper Strategic Divisions Novo Nordisk, the Danish pharmaceutical giant behind blockbuster drugs Ozempic and Wegovy, is experiencing…
ARK Invest CEO Cathie Wood has launched a strong critique against proxy advisory firms recommending shareholders reject Elon Musk’s proposed compensation package. The investment manager argues that index funds’ outsized voting power represents a “broken” system that threatens innovation at companies like Tesla.
Investment manager Cathie Wood has publicly criticized proxy advisory firms for their recommendations against Elon Musk’s proposed $1 trillion compensation package at Tesla, according to reports. In social media posts, Wood described the situation as “sad, if not damning” and questioned the influence these firms wield over shareholder voting processes.